Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Cancer Investigation
|
January 1, 1990
Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma
V Zagonel, U Tirelli, A Carbone, et al.
British Journal of Clinical Pharmacology
|
December 12, 2001
Population pharmacokinetics and pharmacodynamics of oral etoposide
G Toffoli, G Corona, R Sorio, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors
M L Zanette, U Tirelli, R Sorio, et al.
Tumori
|
January 1, 1995
Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature
D Crivellari, A Carbone, R Sigon, et al.
International Journal of Cancer
|
May 16, 1998
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer
G Toffoli, A Russo, A Gallo, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 26, 2004
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin
G Toffoli, R Sorio, B Basso, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Flavone acetic acid distribution in human malignant tumors
G Damia, A Freschi, R Sorio, et al.
Oncology
|
January 1, 1990
Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion
P G Montaldo, F Figoli, M L Zanette, et al.
Anti-Cancer Drugs
|
December 10, 1999
Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma
G Corona, P Aita, R Sorio, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion
F Figoli, M L Zanette, U Tirelli, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Cancer Investigation
|
January 1, 1990
Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma
V Zagonel, U Tirelli, A Carbone, et al.
British Journal of Clinical Pharmacology
|
December 12, 2001
Population pharmacokinetics and pharmacodynamics of oral etoposide
G Toffoli, G Corona, R Sorio, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors
M L Zanette, U Tirelli, R Sorio, et al.
Tumori
|
January 1, 1995
Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature
D Crivellari, A Carbone, R Sigon, et al.
International Journal of Cancer
|
May 16, 1998
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer
G Toffoli, A Russo, A Gallo, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 26, 2004
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin
G Toffoli, R Sorio, B Basso, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Flavone acetic acid distribution in human malignant tumors
G Damia, A Freschi, R Sorio, et al.
Oncology
|
January 1, 1990
Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion
P G Montaldo, F Figoli, M L Zanette, et al.
Anti-Cancer Drugs
|
December 10, 1999
Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma
G Corona, P Aita, R Sorio, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion
F Figoli, M L Zanette, U Tirelli, et al.
Page
of 6